How Denosumab and Anti-Angiogenic Cancer Drugs Affect All-on-4 Dental Implant Success
Dental implants offer a permanent solution for patients seeking to restore their smile and quality of life—but if you’re taking denosumab (Prolia or Xgeva) for osteoporosis or bone metastases, or anti-angiogenic drugs for cancer treatment, you need specialized guidance. Medication-related osteonecrosis of the jaw (MRONJ) is a serious but manageable concern that requires expert evaluation […]